Collinson’s global medical director says countries will increasingly move away from community testing and instead require only symptomatic individuals to be tested, particularly with virus variants become less potent
Vaccines from companies including Pfizer, Moderna and AstraZeneca have slashed hospitalisations and deaths, with more than 12 billion doses administered across the planet